Integrated Historical Cash Flow
| IDHC Stock | 0.44 0.01 2.22% |
Analysis of Integrated Diagnostics cash flow over time is an excellent tool to project Integrated Diagnostics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 421.3 M or Capital Expenditures of 179.8 M as it is a great indicator of Integrated Diagnostics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Integrated Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Integrated Diagnostics is a good buy for the upcoming year.
Integrated |
About Integrated Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Integrated balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Integrated's non-liquid assets can be easily converted into cash.
Integrated Diagnostics Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Integrated Diagnostics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Integrated Diagnostics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Integrated Diagnostics financial statement analysis. It represents the amount of money remaining after all of Integrated Diagnostics Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Integrated Diagnostics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Integrated Diagnostics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Integrated Diagnostics' Depreciation is comparatively stable compared to the past year. Total Cash From Operating Activities is likely to gain to about 669.2 M in 2024, whereas Change In Cash is likely to drop slightly above 24.5 M in 2024.
Integrated Diagnostics cash flow statement Correlations
Click cells to compare fundamentals
Integrated Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Integrated Diagnostics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 4.9M | (17.1M) | (127.6M) | (30.2M) | (104.9M) | (99.7M) | |
| Change In Cash | (3.7M) | 191.2M | 291.3M | (242.9M) | 25.7M | 24.5M | |
| Free Cash Flow | 479.4M | 756.5M | 2.0B | (100.1M) | 217.7M | 206.8M | |
| Change In Working Capital | (58.8M) | (105.7M) | 118.4M | (250.3M) | (387.9M) | (368.5M) | |
| Other Cashflows From Financing Activities | (72.8M) | (87.4M) | (143.0M) | (167.2M) | (86.0M) | (81.7M) | |
| Depreciation | 153.5M | 185.4M | 238.6M | 317.3M | 401.2M | 421.3M | |
| Other Non Cash Items | 17.6M | 18.4M | 4.9M | (704.4M) | (199.9M) | (189.9M) | |
| Capital Expenditures | 218.0M | 126.0M | 263.7M | 308.8M | 325.9M | 179.8M | |
| Total Cash From Operating Activities | 697.4M | 882.5M | 2.3B | 208.7M | 543.7M | 669.2M | |
| Change To Account Receivables | (78.2M) | (140.6M) | (106.5M) | (53.4M) | (198.1M) | (188.2M) | |
| Net Income | 758.1M | 969.1M | 2.2B | 853.6M | 737.4M | 723.7M | |
| Total Cash From Financing Activities | (548.7M) | (563.5M) | (647.1M) | (1.6B) | (330.5M) | (347.0M) | |
| End Period Cash Flow | 408.9M | 600.1M | 891.5M | 648.5M | 674.3M | 596.0M | |
| Other Cashflows From Investing Activities | 59.8M | 51.4M | 111.4M | 106.1M | 73.2M | 76.9M | |
| Investments | 18.3M | (55.0M) | (1.3B) | 990.1M | (243.9M) | (231.7M) | |
| Net Borrowings | 46.2M | (84.6M) | (56.4M) | (54.6M) | (49.1M) | (46.7M) | |
| Begin Period Cash Flow | 412.6M | 408.9M | 600.1M | 891.5M | 648.5M | 556.5M | |
| Total Cashflows From Investing Activities | (465.6M) | (136.4M) | (124.3M) | (1.3B) | (1.2B) | (1.1B) | |
| Dividends Paid | 450.5M | 450.7M | 478.7M | 1.4B | 1.6B | 1.7B | |
| Change To Operating Activities | 143K | (9.3M) | (1.9M) | 681K | 612.9K | 643.5K | |
| Change To Netincome | 51.4M | 91.6M | 208.9M | 500.2M | 575.2M | 604.0M | |
| Change To Liabilities | 64.4M | 23.7M | 53.8M | 351.8M | 404.6M | 424.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.